Literature DB >> 70407

Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.

P Stevens, L S Young.   

Abstract

Previous work has demonstrated that 40% of clinically isolated Escherichia coli are resistant to in vitro killing by normal human polymorphonuclear granulocytes (PMN) due to ineffective opsonophagocytosis. Using these E. coli isolates, we have demonstrated the usefulness of measuring the chemiluminescence (CL) of granulocytes undergoing phagocytosis in detecting this impaired opsonization. CL correlated well with several other methods to assess PMN function including in vitro killing assays, postphagocytic O2 consumption, and morphological phagocytic indexes. Of the available methods to assess granulocyte function, CL is the most rapid and simple and would appear to be a potentially useful screening method to determine possible opsonic deficiencies of human PMNs and serum. Impaired opsonization to these resistant E. coli isolates was demonstrable in several different donors and could be reversed by type-specific rabbit antibody to the particular resistant isolate. Bacterial levels of superoxide dismutase and catalase, enzymes which have been implicated as possible virulence factors in some microorganisms, did not correlate with resistance in these E. coli isolates. However, heat denaturation of these isolates reversed this resistance and would suggest heat-labile antigenic determinants present in E. coli as possible resistance factors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70407      PMCID: PMC421032          DOI: 10.1128/iai.16.3.796-804.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The role of PH in the chemiluminescent response of the myeloperoxidase-halide-HOOH antimicrobial system.

Authors:  R C Allen
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

2.  The superoxide anion and singlet molecular oxygen: their role in the microbicidal activity of the polymorphonuclear leukocyte.

Authors:  R C Allen; S J Yevich; R W Orth; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

3.  Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.

Authors:  I M Goldstein; D Roos; H B Kaplan; G Weissmann
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

4.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

5.  Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte interaction.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Oxygen toxicity and the superoxide dismutase.

Authors:  E M Gregory; I Fridovich
Journal:  J Bacteriol       Date:  1973-06       Impact factor: 3.490

7.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

8.  Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; D Mullikin; P S Shirley; C E McCall
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  Studies on hemagglutination and hemolysis by escherichia coli antisera.

Authors:  E NETER; L F BERTRAM; D A ZAK; M R MURDOCK; C E ARBESMAN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

View more
  23 in total

1.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  [Measuring chemiluminescence in phagocytic granulocytes--simultaneously a parameter of their killing function?].

Authors:  L Dziwisch; B Kremer; J Heesemann; D Bornholdt; D Henne-Bruns
Journal:  Langenbecks Arch Chir       Date:  1987

3.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.

Authors:  B J Stoll; M Pollack; L S Young; N Koles; R Gascon; G B Pier
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 5.  Assessment of neutrophil function--II. Laboratory tests of neutrophil function.

Authors:  E N Wardle
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

6.  Opsonization of various capsular (K) E. coli by the alternative complement pathway.

Authors:  P Stevens; L S Young; S Adamu
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

7.  Inhibition of phagocytosis and chemiluminescence in human leukocytes by a lipid soluble factor in normal tissues.

Authors:  T S Huang; R E Hurd; I J Chopra; P Stevens; D H Solomon; L S Young
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Authors:  S L Kaplan; C L Umstead; E O Mason; D C Anderson; J C Parke; R D Feigin
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

10.  Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

Authors:  A C Issekutz; S Bhimji; R Bortolussi
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.